1. P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey
- Author
-
Erdal, M. Akgül, primary, Büyükşahin, H. Nayır, additional, Şen, V., additional, Kılınç, A. Ayzıt, additional, Çokuğraş, H., additional, Demir, A. Doğan, additional, Doğan, G., additional, Yılmaz, A.İ., additional, Ünal, G., additional, Serbes, M., additional, Altıntaş, D.U., additional, Keskin, Ö., additional, Özaslan, M.M., additional, Karcıoğlu, O., additional, Köse, M., additional, Basaran, A.E., additional, Çakır, E.P., additional, Canıtez, Y., additional, Özdemir, A., additional, Harmancı, K., additional, Uytun, S., additional, Polat, S. Eryılmaz, additional, Hangül, M., additional, Yüksel, H., additional, Özcan, G., additional, Korkmaz, P., additional, Kiliç, M., additional, Aydın, Z.G. Gayretli, additional, Çaltepe, G., additional, Can, D., additional, Doğru, S., additional, Öztürk, G. Kartal, additional, Süleyman, A., additional, Topal, E., additional, Özsezen, B., additional, Hızal, M., additional, Demirdöğen, E., additional, Ogun, H., additional, Börekçi, Ş., additional, Yazan, H., additional, Şen, H. Selimoğlu, additional, Çakır, E., additional, Eyüboğlu, T. Şişmanlar, additional, Emiralioğlu, N., additional, Pekcan, S., additional, Özçelik, U., additional, and Doğru, D., additional
- Published
- 2023
- Full Text
- View/download PDF